Aim Electronic healthcare record (EHR)-based surveillance systems are increasingly being developed to support early detection of safety signals. It is unknown what the power of such a system is for surveillance among children and adolescents. In this paper we provide estimates of the number and classes of drugs, and incidence rates (IRs) of events, that can be monitored in children and adolescents (0-18 years). Methods Data were obtained from seven population-based EHR databases in Denmark, Italy, and the Netherlands during the period 1996-2010. We estimated the number of drugs for which specific adverse events can be monitored as a function of actual drug use, minimally detectable relative risk (RR) and IRs for 10 events. Results The population comprised 4 838 146 individuals (25 575 132 person years (PYs)), who were prescribed 2170 drugs (1 610 631 PYs drug-exposure). Half of the total drug-exposure in PYs was covered by only 18 drugs (0.8%). For a relatively frequent event like upper gastrointestinal bleeding there were 39 drugs for which an association with a RR ≥4, if present, could be investigated. The corresponding number of drugs was eight for a rare event like anaphylactic shock. Conclusion Drug use in children is rare and shows little variation. The number of drugs with enough exposure to detect rare adverse events in children and adolescents within an EHR-based surveillance system such as EU-ADR is limited. Use of additional sources of paediatric drug exposure information and global collaboration are imperative in order to optimize EHR data for paediatric safety surveillance.

Additional Metadata
Keywords active drug safety surveillance, electronic healthcare records, EU-ADR, paediatric drug safety, pharmacovigilance, safety monitoring
Persistent URL dx.doi.org/10.1111/bcp.12610, hdl.handle.net/1765/82572
Journal British Journal of Clinical Pharmacology
Grant This work was funded by the European Commission 7th Framework Programme; grant id fp7/215847 - Exploring and understanding adverse drug reactions by integrative mining of clinical records and biomedical knowledge (EU-ADR)
Citation
de Bie, S, Coloma, P.M, Ferrajolo, C, Verhamme, K.M.C, Trifirò, G, Schuemie, M.J, … Sturkenboom, M.C.J.M. (2015). The role of electronic healthcare record databases in paediatric drug safety surveillance: A retrospective cohort study. British Journal of Clinical Pharmacology, 80(2), 304–314. doi:10.1111/bcp.12610